ProjectTAURIEL-Studie – PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY,…
Basic data
Acronym:
TAURIEL-Studie
Title:
PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY, AND SAFETY STUDY OF MTAU9937A IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER`S DISEASE
Duration:
15/10/2018 to 14/09/2022
Abstract / short description:
Placebo-Kontrollierte Studie mit einem Antikörper gegen das Tau-Protein bei Alzheimer-Patienten in einem frühen Krankheitsstadium.
Keywords:
psychiatry
Psychiatrie
Alzheimer-Demenz
Tau-Antikörper
Involved staff
Managers
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Preische, Oliver
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Zeller, Anja
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Buchmann, Martina
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of General psychiatry and psychotherapy with outpatient clinic
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Neu-Isenburg, Hessen, Germany